rEVO Biologics (United States)

Recent papers from rEVO Biologics (United States)

1. Moderate‐Intensity Exercise Maintains Redox Homeostasis for Cardiovascular HealthAdvanced Biology · 2023
2. Genetic, Structural, and Functional Evidence Link TMEM175 to SynucleinopathiesAnnals of Neurology · 2019
3. Engineering an anti-CD52 antibody for enhanced deamidation stability.mAbs · 2019
4. Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical DataAmerican Journal of Perinatology · 2015
5. Perioperative and peripartum prevention of venous thromboembolism in patients with hereditary antithrombin deficiency using recombinant antithrombin therapyENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 2014
6. Pharmacokinetics of Recombinant Human Antithrombin in Delivery and Surgery Patients With Hereditary Antithrombin DeficiencyClinical and Applied Thrombosis/Hemostasis · 2013
7. Exploring the Role of Antithrombin Replacement for the Treatment of Preeclampsia: A Prospective Randomized Evaluation of the Safety and Efficacy of Recombinant Antithrombin in Very Preterm Preeclampsia ( PRESERVE ‐1)American Journal of Reproductive Immunology · 2013
8. Murine Antithymocyte Globulin T-Cell Depletion Is Mediated Predominantly by Macrophages, but the Fas/FasL Pathway Selectively Targets Regulatory T CellsTransplantation · 2011
9. In Vivo Characterization of Rabbit Anti-Mouse Thymocyte Globulin: A Surrogate for Rabbit Anti-Human Thymocyte GlobulinTransplantation · 2009
10. Long-term Outcome for Large Meniscal Defects Treated with Small Intestinal Submucosa in a Dog ModelThe American Journal of Sports Medicine · 2005